Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Coresh

Showing results (531-540 of 1,160) with videos related to

Pageof 116
Sort By:
Journal of the American Society of Nephrology : JASN|July 15, 2020
The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKDJung-Im Shin, Yingying Sang, Alex R Chang, et al.
JAMA|January 30, 2004
Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutritionYongmei Liu, Josef Coresh, Joseph A Eustace, et al.
Diabetologia|March 11, 2022
Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities studyJustin B Echouffo-Tcheugui, Natalie Daya, Chiadi E Ndumele, et al.
BMC Medical Genetics|October 27, 2009
Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic StudyAudrey Y Chu, Rulan S Parekh, Brad C Astor, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2016
Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) StudyShoshana H Ballew, Yan Chen, Natalie R Daya, et al.
International Journal of Cardiology|April 17, 2015
Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort StudyJohn W McEvoy, Mariana Lazo, Yuan Chen, et al.
Journal of the American Heart Association|September 20, 2014
Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities studyAlvaro Alonso, Jeffrey R Misialek, John H Eckfeldt, et al.
American Journal of Epidemiology|February 21, 2016
Temporal Trends in Hospitalization for Acute Decompensated Heart Failure in the United States, 1998-2011Sunil K Agarwal, Lisa Wruck, Miguel Quibrera, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 23, 2014
Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities studyCasey M Rebholz, Brad C Astor, Morgan E Grams, et al.
American Heart Journal|September 1, 2014
Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) studyAaron R Folsom, Alvaro Alonso, Jeffrey R Misialek, et al.
Pageof 116

Showing results (531-540 of 1,160) with videos related to

Sort By:
Pageof 116
Journal of the American Society of Nephrology : JASN|July 15, 2020
The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKDJung-Im Shin, Yingying Sang, Alex R Chang, et al.
JAMA|January 30, 2004
Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutritionYongmei Liu, Josef Coresh, Joseph A Eustace, et al.
Diabetologia|March 11, 2022
Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities studyJustin B Echouffo-Tcheugui, Natalie Daya, Chiadi E Ndumele, et al.
BMC Medical Genetics|October 27, 2009
Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic StudyAudrey Y Chu, Rulan S Parekh, Brad C Astor, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2016
Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) StudyShoshana H Ballew, Yan Chen, Natalie R Daya, et al.
International Journal of Cardiology|April 17, 2015
Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort StudyJohn W McEvoy, Mariana Lazo, Yuan Chen, et al.
Journal of the American Heart Association|September 20, 2014
Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities studyAlvaro Alonso, Jeffrey R Misialek, John H Eckfeldt, et al.
American Journal of Epidemiology|February 21, 2016
Temporal Trends in Hospitalization for Acute Decompensated Heart Failure in the United States, 1998-2011Sunil K Agarwal, Lisa Wruck, Miguel Quibrera, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 23, 2014
Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities studyCasey M Rebholz, Brad C Astor, Morgan E Grams, et al.
American Heart Journal|September 1, 2014
Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) studyAaron R Folsom, Alvaro Alonso, Jeffrey R Misialek, et al.
Pageof 116